Role of matrix metalloproteinases in the pathogenesis of intracranial aneurysms.

Intracranial aneurysms (IAs) are a result of complex interactions between biochemical and mechanical forces and can lead to significant morbidity if they rupture and cause subarachnoid hemorrhage. This review explores the role of matrix metalloproteinases (MMPs) in the pathogenesis and progression of IAs. In addition to providing a review of the normal function of MMPs, it is intended to explore the interaction between inflammation and abnormal blood flow and the resultant pathological vascular remodeling processes seen in the development and rupture of IAs. Also reviewed is the potential for the use of MMPs as a diagnostic tool for assessment of aneurysm development and progression.

[1]  J. Lindholt,et al.  The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[2]  M. Taneda,et al.  Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. , 1999, Stroke.

[3]  S. Galetta,et al.  The clinical spectrum of unruptured intracranial aneurysms. , 1993, Archives of neurology.

[4]  Masafumi Morimoto,et al.  Macrophage-Derived Matrix Metalloproteinase-2 and -9 Promote the Progression of Cerebral Aneurysms in Rats , 2007, Stroke.

[5]  D. Chyatte,et al.  Inflammation and intracranial aneurysms. , 1999, Neurosurgery.

[6]  J. Xiang,et al.  High WSS or Low WSS? Complex Interactions of Hemodynamics with Intracranial Aneurysm Initiation, Growth, and Rupture: Toward a Unifying Hypothesis , 2014, American Journal of Neuroradiology.

[7]  T. Yamashita,et al.  Loss and apoptosis of smooth muscle cells in intracranial aneurysms studies with in situ DNA end labeling and antibody against single-stranded DNA , 2005, Acta Neurochirurgica.

[8]  K. Nozaki,et al.  Impact of Monocyte Chemoattractant Protein-1 Deficiency on Cerebral Aneurysm Formation , 2009, Stroke.

[9]  J. Quigley,et al.  Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. , 1995, The Journal of biological chemistry.

[10]  E. Connolly,et al.  Matrix metalloproteinase-9 in cerebral aneurysms. , 1997, Neurosurgery.

[11]  Timothy C Greiner,et al.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.

[12]  D. Matthews,et al.  Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch. , 2008, Biochemistry.

[13]  A. Algra,et al.  Prevalence and risk of rupture of intracranial aneurysms: a systematic review. , 1998, Stroke.

[14]  A C Burleson,et al.  Identification of Quantifiable Hemodynamic Factors in the Assessment of Cerebral Aneurysm Behavior On behalf of the Subcommittee on Biorheology of the Scientific and Standardization Committee of the ISTH , 1996, Thrombosis and Haemostasis.

[15]  M. Thompson,et al.  Matrix Metalloproteinase-8 and -9 Are Increased at the Site of Abdominal Aortic Aneurysm Rupture , 2005, Circulation.

[16]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.

[17]  H Yonas,et al.  Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. , 1999, Stroke.

[18]  M. Lawton,et al.  Critical Roles of Macrophages in the Formation of Intracranial Aneurysm , 2011, Stroke.

[19]  Y. Cho,et al.  Intracranial aneurysms: flow analysis of their origin and progression. , 1992, AJNR. American journal of neuroradiology.

[20]  S. Fisher,et al.  The significance of the extracellular matrix in intracranial aneurysms. , 1993, Annals of clinical and laboratory science.

[21]  F. Tancioni,et al.  Metalloproteases and intracranial vascular lesions. , 1999, Neurological research.

[22]  T Ishii,et al.  Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. , 2000, Human pathology.

[23]  D. Werring,et al.  Association of functional MMP-2 gene variant with intracranial aneurysms: case-control genetic association study and meta-analysis , 2018, British journal of neurosurgery.

[24]  H. Winn,et al.  Upregulation of Cyclooxygenase-2 (COX-2) and Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) in Wall of Ruptured Human Cerebral Aneurysms: Preliminary Results , 2012, Stroke.

[25]  W. Koch,et al.  Biology of Intracranial Aneurysms: Role of Inflammation , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  J. Frösen.  Smooth Muscle Cells and the Formation, Degeneration, and Rupture of Saccular Intracranial Aneurysm Wall—a Review of Current Pathophysiological Knowledge , 2014, Translational Stroke Research.

[27]  F. Gomis-Rüth,et al.  Matrix metalloproteinases: fold and function of their catalytic domains. , 2010, Biochimica et biophysica acta.

[28]  H. Kikuchi,et al.  Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. , 1998, Stroke.

[29]  W. Koch,et al.  The role of oxidative stress in cerebral aneurysm formation and rupture. , 2013, Current neurovascular research.

[30]  D. Giddens,et al.  Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. , 2003, The Journal of biological chemistry.

[31]  S. Katsuda,et al.  Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. , 1994, The American journal of pathology.

[32]  K. Suzuki,et al.  Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. , 1994, The Journal of biological chemistry.

[33]  K. Katada,et al.  Magnitude and Role of Wall Shear Stress on Cerebral Aneurysm: Computational Fluid Dynamic Study of 20 Middle Cerebral Artery Aneurysms , 2004, Stroke.

[34]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[35]  E. Choke,et al.  Elevated plasma MMP1 and MMP9 are associated with abdominal aortic aneurysm rupture. , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[36]  M. Baumann,et al.  Oxidative stress is associated with cell death, wall degradation, and increased risk of rupture of the intracranial aneurysm wall. , 2013, Neurosurgery.

[37]  Robert D. Brown,et al.  Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm Rupture , 2011, Stroke.

[38]  S. Juvela,et al.  Factors Affecting Formation and Growth of Intracranial Aneurysms: A Long-Term Follow-Up Study , 2001, Stroke.

[39]  Y. Hua,et al.  Aspirin Inhibits MMP-2 and MMP-9 Expressions and Activities through Upregulation of PPARα/γ and TIMP Gene Expressions in ox-LDL-Stimulated Macrophages Derived from Human Monocytes , 2008, Pharmacology.

[40]  James P. Quigley,et al.  Matrix Metalloproteinase-2 Is an Interstitial Collagenase , 1995, The Journal of Biological Chemistry.

[41]  C. Lapière,et al.  Collagenolytic activity in amphibian tissues: a tissue culture assay. , 1962, Proceedings of the National Academy of Sciences of the United States of America.

[42]  V. Sandrim,et al.  Levels of MMP-9 in patients with intracranial aneurysm: Relation with risk factors, size and clinical presentation. , 2018, Clinical biochemistry.

[43]  P. Libby,et al.  Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.

[44]  Johnson Huang,et al.  The Probability of Sudden Death from Rupture of Intracranial Aneurysms: A Meta-analysis , 2002, Neurosurgery.

[45]  P. Libby,et al.  Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Hovsepian,et al.  Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. , 2000, Journal of vascular and interventional radiology : JVIR.

[47]  M. Shono,et al.  Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: experimental study in rats. , 2007, Journal of neurosurgery.

[48]  Aki Laakso,et al.  Saccular intracranial aneurysm: pathology and mechanisms , 2012, Acta Neuropathologica.

[49]  J. Parisi,et al.  Sudden death from aneurysmal subarachnoid hemorrhage , 1995, Neurology.

[50]  D. Kallmes,et al.  Neurovascular manifestations of connective-tissue diseases: A review , 2016, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[51]  É. Allaire,et al.  Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. , 1998, The Journal of clinical investigation.

[52]  M. Lipton.  Intracranial aneurysms. , 1997, The New England journal of medicine.

[53]  N. Cerdà-Costa,et al.  Architecture and function of metallopeptidase catalytic domains , 2014, Protein science : a publication of the Protein Society.

[54]  Jun Sheng,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm. , 2007, Surgical neurology.

[55]  K. Nozaki,et al.  Role of TIMP-1 and TIMP-2 in the Progression of Cerebral Aneurysms , 2007, Stroke.

[56]  W. Pearce,et al.  Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. , 1999, Journal of vascular surgery.

[57]  NobuoHashimoto,et al.  Impaired Progression of Cerebral Aneurysms in Interleukin-1β–Deficient Mice , 2006 .

[58]  H. Birkedal‐Hansen,et al.  Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Marko Kangasniemi,et al.  Remodeling of Saccular Cerebral Artery Aneurysm Wall Is Associated With Rupture: Histological Analysis of 24 Unruptured and 42 Ruptured Cases , 2004, Stroke.

[60]  M. Gunel,et al.  Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. , 2005, Neurosurgery.

[61]  N. Greig,et al.  TNF-α Induces Phenotypic Modulation in Cerebral Vascular Smooth Muscle Cells: Implications for Cerebral Aneurysm Pathology , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[62]  Chao You,et al.  Increased apoptosis and cysteinyl aspartate specific protease-3 gene expression in human intracranial aneurysm , 2007, Journal of Clinical Neuroscience.

[63]  K. Nozaki,et al.  Reduced Collagen Biosynthesis Is the Hallmark of Cerebral Aneurysm: Contribution of Interleukin-1&bgr; and Nuclear Factor-&kgr;B , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[64]  C. Kim,et al.  Mechanical stretch enhances the expression and activity of osteopontin and MMP-2 via the Akt1/AP-1 pathways in VSMC. , 2015, Journal of molecular and cellular cardiology.

[65]  D. Dickson,et al.  Immunocytochemical Studies of Atherosclerotic Lesions of Cerebral Berry Aneurysms , 1994, Journal of neuropathology and experimental neurology.